Loading
A phase 2 trial of ZEN-3694 in lung cancer, run by Memorial Sloan Kettering Cancer Center, now recruiting.
A Study of ZEN003694 in People With Squamous Cell Lung Cancer is a phase 2, interventional study registered as NCT05607108 by Memorial Sloan Kettering Cancer Center, with a registry enrolment figure of 13 participants, started 2022-11-01 and due to reach its primary completion in 2027-11. Interventions recorded: ZEN003694. Conditions listed: Squamous Cell Lung Cancer. Primary outcome: overall response rate (ORR). Lung eligibility wording from the registry: "* Histologically-confirmed squamous cell lung cancer". Sites: United States. No results are recorded here; the registry entry is the source.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.